This examination is performed to evaluate elevated PSA levels, suspected prostate cancer, abnormal digital rectal examination (DRE) findings, persistent urinary symptoms, active surveillance of known prostate cancer, pre-biopsy assessment, treatment planning, and follow-up after treatment.